The DOI matches its Crossref record.
Hypertriglyceridemic Waist: A Marker of the Atherogenic Metabolic Triad (Hyperinsulinemia; Hyperapolipoprotein B; Small, Dense LDL) in Men?
Abstract
Background —The present study tested the hypothesis that simple variables, such as waist circumference and fasting plasma triglyceride (TG) concentrations, could be used as screening tools for the identification of men characterized by a metabolic triad of nontraditional risk factors (elevated insulin and apolipoprotein [apo] B and small, dense LDL particles). Methods and Results —Results of the metabolic study (study 1) conducted on 185 healthy men indicate that a large proportion (>80%) of men with waist circumference values ≥90 cm and with elevated TG levels (≥2.0 mmol/L) were characterized by the atherogenic metabolic triad. Validation of the model in an angiographic study (study 2) on a sample of 287 men with and without coronary artery disease (CAD) revealed that only men with both elevated waist and TG levels were at increased risk of CAD (odds ratio of 3.6, P <0.03) compared with men with low waist and TG levels. Conclusions —It is suggested that the simultaneous measurement and interpretation of waist circumference and fasting TG could be used as inexpensive screening tools to identify men characterized by the atherogenic metabolic triad (hyperinsulinemia, elevated apo B, small, dense LDL) and at high risk for CAD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adding biochemical markers, such as plasma triglyceride levels, to the measurement of waist circumference—a phenotype described as hypertriglyceridaemic waist—has been suggested as a useful method for identification of individuals with excess visceral adipose tissue and ectopic fat.51”
From Definition and diagnostic criteria of clinical obesity (2025) · cites this paper as [51]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 28
- 10.1073/pnas.77.1.604 · DOI
- 10.1161/circ.94.3.273 · DOI
- 10.1136/hrt.71.3.293 · DOI
- 10.1056/NEJM199604113341504 · DOI · Paper page
- 10.1161/atv91.12.2.1543692 · DOI
- 10.1161/circ.95.1.69 · DOI
- 10.1001/jama.279.24.1955 · DOI
- 10.2337/diab.41.7.826 · DOI
- 10.1016/0002-9149(94)90676-9 · DOI
- 10.2337/diacare.19.6.629 · DOI · Paper page
- 10.1093/clinchem/28.10.2077 · DOI
- 10.1093/clinchem/20.4.470 · DOI
- 10.1172/JCI103182 · DOI
- 10.1016/0009-8981(60)90075-9 · DOI
- 10.1016/0003-2697(66)90246-6 · DOI
- 10.1016/0026-0495(87)90183-1 · DOI
- 10.1210/jcem-33-5-732 · DOI
- Standardization of anthropometric measurements. In: Lohman T Roche A Martorel R eds. The Airlie (VA) Consensus Conference. Champaign Ill: Human Kinetics; 1988:39–80.
- 10.1079/BJN19890104 · DOI
- 10.1016/S0002-9149(98)00328-2 · DOI
- 10.1161/circ.97.9.871 · DOI
- 10.1016/0009-8981(87)90188-4 · DOI
- 10.1093/clinchem/28.6.1379 · DOI
- 10.1093/clinchem/18.6.499 · DOI · Paper page
- 10.1161/atv91.12.11.1420088 · DOI
- 10.1161/01.CIR.85.1.37 · DOI · Paper page
- 10.1079/NRR19930010 · DOI
- 10.1016/S0140-6736(94)90814-1 · DOI
Cited by
Sorted by citations
Items 601–700 of 819
Shojaei, S., Radkhah, H., Akhlaghipour, I., Shad, A. N., Azarboo, A., & Mousavi, A. (2025) · Heart & Lung · doi:10.1016/j.hrtlng.2025.02.008 · Cited by 6
Murphy-Després, A., Chartrand, D. J., Lemieux, I., Tremblay, A., Bergeron, J., Poirier, P., Alméras, N., & Després, J. (2024) · Nutrients · doi:10.3390/nu16091377 · Cited by 6
Self-citationHe, H., Wang, S., Xu, T.-W., Liu, W.-B., Li, Y.-P., Lu, G.-Y., & Tu, R.-P. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01795-2 · Cited by 6
“Waist circumference was measured by trained assessors using soft measuring tape, and enlarged waist circumference was defined as ≥ 85 cm in females or ≥ 90 cm in males [9, 10].”
BackgroundMethodSaito, K., Shimamoto, T., Takahashi, Y., Okushin, K., Takahashi, M., Masuda, Y., Nishikawa, T., Kakushima, N., Wada, R., & Yamamichi, N. (2022) · Scientific Reports · doi:10.1038/s41598-022-24863-6 · Cited by 7
Prakaschandra, R., & Naidoo, D. P. (2022) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2022.102524 · Cited by 4
Targeting Epicardial Fat in Obesity and Diabetes Pharmacotherapy
Iacobellis, G., Basilico, S., & Malavazos, A. E. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2021_577 · Cited by 8
Cai, R., Zhou, J., Bai, L., Dong, Y., & Ding, W. (2022) · Scientific Reports · doi:10.1038/s41598-022-19690-8 · Cited by 6
Zhang, X., Ding, Y., Shao, Y., He, J., Ma, J., Guo, H., Keerman, M., Liu, J., Si, H., Guo, S., et al. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s306908 · Cited by 8
Chen, G., Yi, Q., Hou, L.-Y., Peng, S., Fan, M., Song, P.-G., & Zhu, Y.-M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18073664 · Cited by 6
“The concept of HTW was first proposed as an index for cardiovascular disease by Lemieux et al. in the late twentieth century [7].”
Guo, V. Y., Yu, E. Y. T., Wong, C. K. H., Sit, R. W. S., Wang, J. H., & Lam, C. L. K. (2018) · Diabetic Medicine · doi:10.1111/dme.13601 · Cited by 6
Utility of three anthropometric indices in assessing the cardiometabolic risk profile in children
Buchan, D. S., Boddy, L., Grace, F., Brown, E. C., Sculthorpe, N., Cunningham, C., Murphy, M., Dagger, R., Foweather, L., Graves, L., et al. (2017) · American Journal of Human Biology · doi:10.1002/ajhb.22934 · Cited by 6
Abbasi, F., Mathur, A., Reaven, G., & Molina, C. (2016) · Ethnicity & Disease · doi:10.18865/ed.26.2.191 · Cited by 6
Linares-Reyes, E., Minaya, K. Y. C., Ríos-Mino, M., & Huamán-Saavedra, J. J. (2014) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.17843/rpmesp.2014.312.42 · Cited by 2
Morales, P. F., Martínez, S., Martínez, P. M., Bermejo, J. B., López, M. S., Martínez, M. S., & Pacheco, B. (2008) · Revista Clínica de Medicina de Familia · doi:10.4321/s1699-695x2008000200003 · Cited by 6
Evaluation of the metabolic syndrome in hypertensive patients: results from the ICEBERG Study.
Kabakci, G., Koylan, N., Kozan, Ö., Buyukozturk, K., & Ilerigelen, B. (2007) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4564.2007.06530.x · Cited by 6
El eslabón perdido del síndrome metabólico: hiperlipemia posprandial y estrés oxidativo
Cardona, F., & Tinahones, F. J. (2006) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(06)71114-7 · Cited by 7
Syndrome métabolique : diagnostic, conséquences cardiaques et vasculaires
Tison, E. (2005) · EMC - Cardiologie-Angéiologie · doi:10.1016/j.emcaa.2005.09.001 · Cited by 6
Woods, P., Paquette, C., Martin, J., Dumesnil, J., Marceau, P., Marceau, S., Biron, S., Hould, F., Lescelleur, O., Lebel, S., et al. (2004) · Cardiovascular Diabetology · doi:10.1186/1475-2840-3-5 · Cited by 6
A Festschrift for Roland L. Weinsier: Nutrition Scientist, Educator, and Clinician1
Heimburger, D. C., Allison, D. B., Goran, M. I., Heini, A. F., Hensrud, D. D., Hunter, G. R., Klein, S., Kumanyika, S. K., Kushner, R. F., Rolls, B. J., et al. (2003) · Obesity Research · doi:10.1038/oby.2003.171 · Cited by 6
Zaragoza-García, O., Navarro-Zarza, J. E., Maldonado-Anicacio, J., Castro-Alarcón, N., Rojas, I. P., & Guzmán-Guzmán, I. P. (2019) · Diabetes & metabolic syndrome · doi:10.1016/j.dsx.2018.11.053 · Cited by 6
Klein, S., Fabbrini, E., & Romijn, J. A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00036-5 · Cited by 4
Salehi, Z., Rahbarinejad, P., Ghosn, B., & Azadbakht, L. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.3991 · Cited by 7
“This index includes insulin resistance with increased serum levels of apolipoprotein B and an increase in the number of small low-density lipoproteins (LDLs) (Lamarche et al., 1998; Lemieux et al., 2000).”
Backgroundda Conceição, A. R., da Silva, A., Juvanhol, L. L., Marcadenti, A., Bersch-Ferreira, Â. C., Weber, B., Shivappa, N., & Bressan, J. (2023) · Nutrition Research · doi:10.1016/j.nutres.2023.10.007 · Cited by 5
Ren, Y., Qiu, Z., Wu, W.-H., Dong, X.-G., Han, S.-Y., Zhang, F.-L., Kong, F.-L., & Li, F.-E. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1024398 · Cited by 5
“LAA, large-artery atherosclerosis; SAO, small-artery occlusion; CE, cardioembolism; SOE and SUE, stroke of other determined etiology and undetermined etiology; NWNT, normal waist– normal blood triglycerides; EWNT, elevated waist–normal blood triglycerides; NWET, normal waist–elevated blood triglycerides; HTWP, hypertr…”
BackgroundInfluentialAssociations between insulin-like growth factor binding protein-2 and lipoprotein kinetics in men
Rauzier, C., Lamarche, B., Tremblay, A. J., Couture, P., & Picard, F. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100269 · Cited by 5
Self-citationXuan, Y., Zhang, W., Wang, Y., Wang, B., Chen, Y., Xia, F., Zhang, K., Li, Q., Wang, N., & Lu, Y. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s359742 · Cited by 7
Xuan, Y., Gao, P., Shen, Y., Wang, S., Gu, X., Tang, D., Wang, X., Zhu, F., Lu, L.-Q., & Chen, L. (2022) · HORMONES · doi:10.1007/s42000-022-00374-x · Cited by 5
Targeting Diet Quality at the Workplace: Influence on Cardiometabolic Risk
Amil, S., Lemieux, I., Poirier, P., Lamarche, B., Després, J., & Alméras, N. (2021) · Nutrients · doi:10.3390/nu13072283 · Cited by 8
“Although not measured, we can speculate that employees of the present study for whom a reduction in waist circumference was observed were also characterized by a reduction in visceral fat as suggested by the decrease in carriers of the hyperTG waist phenotype, a clinical marker of visceral obesity [30,31].”
BackgroundMethodSelf-citationEffects of Melatonin Against Thioacetamide-Induced Testicular Toxicity in Rats
Karabulut, D., Akın, A., Sayan, M., Kaymak, E., Ozturk, E., & Yakan, B. (2020) · doi:10.4067/s0717-95022020000501455 · Cited by 5
Chailurkit, L., Aekplakorn, W., Paiyabhroma, N., & Ongphiphadhanakul, B. (2020) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2020.0013 · Cited by 5
“12 With regard to 11HSD, it has been demonstrated that 11HSD is associated with metabolic syndrome, and 11HSD inhibitors have therapeutic potential for this syndrome.”
Ma, C.-M., & Yin, F.-Z. (2019) · Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy · doi:10.2147/dmso.s204062 · Cited by 5
Armborst, D., Metzner, C., Bitterlich, N., Lemperle, M., & Siener, R. (2019) · International Journal of Food Science and Nutrition · doi:10.1080/09637486.2018.1537363 · Cited by 5
Sonographic Measurement of Visceral Fat and Prediction of Metabolic Syndrome in the Elderly
Hung, C.-Y., Chang, C.-W., Chen, C.-J., Chang, C.-W., Cheng, H., & Chen, M.-J. (2018) · International Journal of Gerontology · doi:10.1016/j.ijge.2018.05.003 · Cited by 5
de Oliveira, C. C., Roriz, A. K. C., Eickemberg, M., Medeiros, J. M. B., & Ramos, L. B. (2014) · PubMed · doi:10.3305/nh.2014.30.1.7411 · Cited by 52
Efeito do treinamento concorrente nos componentes da síndrome metabólica de homens de meia-idade
de Souza, G. V., Libardi, C. A., Rocha, J., Madruga, V. A., & Chacon-Mikahil, M. P. (2012) · Fisioterapia em Movimento · doi:10.1590/s0103-51502012000300020 · Cited by 5
Using waist circumference to screen for metabolic syndrome in an inpatient population.
Patel, P. V., Gilski, D., & Morrison, J. (2010) · Critical Pathways in Cardiology · doi:10.1097/hpc.0b013e3181f005a5 · Cited by 5
Ashen, M. D. (2008) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2008.07.018 · Cited by 7
Assessment of obesity status in outpatients from three disease states
Haroun, D., Jn, W., Lau, C., Hadji-Lucas, E., & Lawson, M. (2006) · Acta paediatrica · doi:10.1080/08035250600702586 · Cited by 5
“Waist circumference (WC) measurement is also useful for assessing risk for obesity-related diseases [6].”
BackgroundLDL heterogeneity revisited: lesson for the metabolic syndrome from a new interpopulation study?
Chan, D. C., & Watts, G. F. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01420.x · Cited by 9
Cholesterol (and cardiovascular risk) in adolescence
Kohn, M. R., & Jacobson, M. S. (2004) · Current Opinion in Pediatrics · doi:10.1097/01.mop.0000133629.49167.3f · Cited by 4
Metabolic syndrome and professional aptitude
Rębak, D., Suliga, E., & Głuszek, S. (2016) · Medical Studies · doi:10.5114/ms.2015.56672 · Cited by 5
“The epidemic of obesity, which has been observed worldwide, affects the dynamics of the occurrence of metabolic syndrome [14, 22, 27].”
BackgroundWaist Circumference and Cardiovascular Risk
Schunkert, H., Markus, M., & Stritzke, J. (2012) · Springer eBooks · doi:10.1007/978-1-4419-1788-1_131 · Cited by 5
Interaction of cells with decellularized biological materials.
Wilhelmi, M., Giere, B., & Harder, M. (2012) · Advances in Biochemical Engineering/Biotechnology · doi:10.1007/10_2011_109 · Cited by 5
New and Emerging Therapeutic Targets for ApoB-Containing Particles Lowering
Gaudet, D., Larouche, M., Raal, F. J., & Catapano, A. L. (2026) · Circulation Research · doi:10.1161/circresaha.126.327270 · Cited by 5
Self-citationGuo, T., He, P., Lu, W., Huang, L., Liu, C., Cheng, B., Zhang, Y., Zhang, Q., Chen, Y., Liu, M., et al. (2025) · Obesity · doi:10.1002/oby.24367 · Cited by 5
“Emerging evidence suggests that integrating waist circumference (WC) with biochemical markers—particularly plasma triglycerides (TG) and apolipoprotein B (ApoB)—may enhance risk stratification accuracy by quantifying both abdominal adiposity topography and VAT-associated dyslipidemia [4].”
Amouzegar, A., Honarvar, M., Masoumi, S., Agahi, S., Azizi, F., & Mehran, L. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-078701 · Cited by 4
Chung, K., Choi, Y., Cho, I.-R., Son, B., Ryu, J., Kim, Y.-T., Lee, S. H., & Han, K. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-071213 · Cited by 4
Piñerúa-Gonsálvez, J. F., Ruiz-Rebollo, M., Zambrano-Infantino, R. D. C., Rizzo-Rodríguez, M. A., & Fernández-Salazar, L. (2023) · Gastroenterology & hepatology · doi:10.1016/j.gastrohep.2023.01.015 · Cited by 4
Bao, Q., Li, Y., Ma, S., Qiu, J., Sun, J., Su, Y., Zhang, A., Cai, S., Cheng, B., Li, M., et al. (2023) · Journal of Clinical Hypertension · doi:10.1111/jch.14604 · Cited by 3
Chen, R., Sun, G., Liu, R., Sun, A., Cao, Y., Zhou, X.-J., & Zhang, S. (2021) · BMC Nephrology · doi:10.1186/s12882-021-02339-5 · Cited by 4
Miñambres, I., Sánchez-Hernandez, J., Cuixart, G., Sánchez-Pinto, A., Sarroca, J., & Pérez, A. (2021) · Revista clínica española (Ed. impresa) · doi:10.1016/j.rceng.2020.06.010 · Cited by 4
Jia, X., Wang, J., Bai, L., Hua, T., Han, Z.-H., & Lü, Q. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.1875428 · Cited by 3
“[3], and has attracted much attention in recent years worldwide.”
BackgroundNgueta, G. (2020) · Cannabis and Cannabinoid Research · doi:10.1089/can.2019.0048 · Cited by 5
Nolin, M.-A., Demers, M., Rauzier, C., Bouchard, R., Cadrin, C., Despres, J., Roy, M., Alméras, N., & Picard, F. (2020) · World Journal of Biological Psychiatry · doi:10.1080/15622975.2020.1770858 · Cited by 4
“…ATP III criteria for the clinical diagnosis of the metabolic syndrome (Brown 2004), including hypertriglyceridemic (hyperTG) waist phenotype (in men, waist circumference 90 cmþ plasma TG 2.0mmol/L), a simple clinical marker of visceral obesity and a robust atherogenic marker (Lemieux et al. 2000).”
BackgroundMethodSelf-citationJiang, B., Gu, T., Zhou, K., Zheng, Y., Guo, Y., & Lu, Y. (2018) · International Journal of Endocrinology · doi:10.1155/2018/7903982 · Cited by 3
“The reason is that central obesity, as assessed by WC, is highly correlated with insulin sensitivity, cardiovascular disease, and the other metabolic syndrome components, and central obesity could be an early step in the etiological cascade leading to full metabolic syndrome [3].”
Backgroundde Andrade, J. R., Velásquez-Meléndez, G., Barreto, S. M., Pereira, T. S. S., Mill, J. G., & Molina, M. D. C. B. (2017) · Revista Brasileira de Epidemiologia · doi:10.1590/1980-5497201700030003 · Cited by 6
Weschenfelder, C., Marcadenti, A., Stein, A., & Gottschall, C. (2017) · Sao Paulo medical journal = Revista paulista de medicina · doi:10.1590/1516-3180.2016.004519102016 · Cited by 4
Haack, R., Horta, B., Gigante, D., Barros, F., Oliveira, I., & Silveira, V. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134121 · Cited by 4
Tangvarasittichai, S., Seangsuk, C., Chaisomboon, C., Meemark, S., & Tangvarasittichai, O. (2015) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-015-0302-7 · Cited by 4
“eTGWC phenotype is a marker of the atherogenic metabolic triad that includes hyperinsulinemia, hyperapolipoprotenemia, and small density low-density lipoprotein cholesterol [13, 16].”
BackgroundInfluentialYang, R.-F., Lin, Z., Liu, X.-Y., & Zhang, G. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-9906-7 · Cited by 4
“The hypertriglyceridemic waist phenotype (HTWP), a combination of high waist circumference measurement and hypertriglyceridemia, is considered to be a useful marker and an inexpensive simple screening method to identify the metabolic disorders triad (hyperinsulinemia; hyperapolipoprotein B; elevated small, dense LDL)…”
Nussbaumerova, B., Rosolová, H., Mayer, O., Filipovský, J., Cífková, R., & Bruthans, J. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.06.567 · Cited by 4
Ethnicity differences in plasma apoC-III levels between African American and Caucasian youths
Lee, J., Hong, H.-R., & Kang, H. (2011) · World Journal of Pediatrics · doi:10.1007/s12519-011-0266-8 · Cited by 4
Associations between abdominal adiposity, exercise, morbidity, and mortality
Kuk, J. L. (2007) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-090 · Cited by 4
Comment prendre en charge le syndrome métabolique
Andreelli, F., & Ziegler, O. (2005) · Annales d Endocrinologie · doi:10.1016/s0003-4266(05)81744-5 · Cited by 4
“, est extrêmement simple puisqu’elle repose sur l’association de deux critères, un taux de triglycérides supérieur ou égal à 2 mmol/l et un tour de taille supérieur ou égal à 90 cm, caractérisant le phénotype de “tour de taille (ou taille) hypertriglycéridémiant(e)”, devant permettre, selon ces auteurs, de dépister cl…”
Amiri, P., Naghizadeh, M., Baradaran, B., Saghafi‐Asl, M., Shanehbandi, D., & Mirmajidi, S. (2018) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-018-0626-1 · Cited by 2
Gender Differences in Metabolic Syndrome
Rochlani, Y. M., Andries, G., Yandrapalli, S., Pothineni, N. V. K., & Mehta, J. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-71135-5_2 · Cited by 4
Moez, R., & Said, A. (2016) · doi:10.5455/ijtrr.000000145 · Cited by 4
Serum Leptin Correlated with Anthropometric Indices in obese Subjects
MO, O. D. E. (2014) · Journal of Metabolic Syndrome · doi:10.4172/2167-0943.1000157 · Cited by 2
Parámetros lipídicos y objetivos terapéuticos
Cordero, A., Sirera, D., & Bertoméu, V. (2012) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(12)70040-7 · Cited by 5
Li, Q., Liu, Z., & Zhang, X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1644381 · Cited by 3
Losinski, G., Key, M. N., Vidoni, E. D., Clutton, J. E., Morris, J. K., Burns, J. M., & Watts, A. S. (2025) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2025.1531062 · Cited by 5
Torun, C., & Ankarali, H. (2025) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2025.0005 · Cited by 3
“8 This concept builds on the complex phenotype of visceral obesity, which includes adipose tissue storage dysfunction and ectopic triglyceride deposition in various areas, including the liver.”
O’Bryan, E., McKay, C. D., Eades, S., Gubhaju, L., Pearson, O. R., Kerr, J. A., Brown, A. D. H., & Azzopardi, P. S. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20136228 · Cited by 5
Association between hypertriglyceridemic waist phenotype and hypogonadism in Taiwanese adult men
Wang, S.-K., Lee, M., Hung, C.-L., Chen, H.-H., Liao, C., & Chiu, Y. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265629 · Cited by 3
Visceral adiposity indicators and cardiovascular risk in hemodialytic patients
Melo, D. D. A., dos Santos, A. D., Furtado, E., França, A. K., dos Santos, E. D., de Arruda, I. D., de Carvalho, T. R., Pinho, C. P. S., Diniz, A. D. S., & de Lemos, M. D. C. C. (2021) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000421 · Cited by 3
Silva, L. C. D. S. E., Silva, S. L. B. E., de Oliveira, Á. M. S., de Araújo, J. R., de Arruda, I. D., Maio, R., & de Lemos, M. D. C. C. (2020) · Revista Paulista de Pediatria · doi:10.1590/1984-0462/2020/38/2019073 · Cited by 3
Visceral Fat Area Evaluation by Computed Tomography Correlates with Visceral Fat Volume
Mizui, M., Mizoguchi, Y., Senda, Y., Yokoi, M., & Tashiro, T. (2017) · Global Journal of Health Science · doi:10.5539/gjhs.v9n10p78 · Cited by 3
“(DeFronzo & Ferrannini, 1991; Fujioka, Matsuzawa, Tokunaga, & Tarui, 1987; Lemieux et al., 2000) Traditionally, the body mass index (BMI) has been used as a measure of abdominal obesity; however, in recent years, more and more studies use measures of visceral fat.”
BackgroundChen, K., Li, P., Li, Y.-J., Li, T., & Mu, Y. (2016) · Postgraduate medicine · doi:10.1080/00325481.2016.1214060 · Cited by 3
“[24] CAD British N = 185 men, mean age = 43.”
BackgroundHUBUNGAN INDEKS MASSA TUBUH DAN ASUPAN ASAM LEMAK JENUH DENGAN RASIO LDL/HDL SERUM LANSIA
Affanti, K. A. N., & AryuCandra, K. (2015) · doi:10.14710/jnc.v4i2.10064 · Cited by 3
“Hal ini sesuai dengan penelitian sebelumnya yaitu pada penelitian Lemieux Let al yang menyatakan bahwa IMT yang semakin meningkat berhubungan dengan meningkatnya kadar kolesterol, menurunkan HDL,dan meningkatkan LDL.(15) Selain itu, berdasarkan analisis multivariat IMT memiliki hubungan yang signifikan dibanding denga…”
BackgroundOriginal, I., Ruiz-Fernández, N., Rangel, A., Rodríguez, C., Rodríguez, L., & Rodríguez, V. (2015) · Revista de la Facultad de Medicina · doi:10.15446/revfacmed.v63n2.49185 · Cited by 3
Clinical Strategies for Managing Dyslipidemias
Bronas, U. G., & Salisbury, D. L. (2013) · American Journal of Lifestyle Medicine · doi:10.1177/1559827613507534 · Cited by 5
Sakata, S., Ito, M., Mera, Y., Sasase, T., Yamamoto, H., Kakutani, M., & Ohta, T. (2014) · Journal of Diabetes Research · doi:10.1155/2014/803832 · Cited by 3
“suggested that visceral obesity and the hypertriglyceridemic waist phenotype are central components [4].”
Outcome of adrenal tissue fragments allotransplantation: the impact of cryopreservation.
Alabedalkarim, N., Bozhok, G., Legach, E., Ustichenko, V., Zubov, P., Bilyavskaya, S. B., Dudetskaya, G., Bondarenko, T., & Hoffmann, M. (2012) · Cryobiology · doi:10.1016/j.cryobiol.2012.05.013 · Cited by 3
García, C. S., Barrera, F., Labbé, P., Liberona, J., Arrese, M., Irarrazabal, P., Tejos, C., & Uribe, S. (2012) · Revista médica de Chile (Impresa) · doi:10.4067/s0034-98872012001200003 · Cited by 3
Kuba, V. M. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2012.tde-25042012-102817 · Cited by 1
Clinical Evaluation for Genetic and Secondary Causes of Dyslipidemia
Stone, N. J. (2009) · Elsevier eBooks · doi:10.1016/b978-141605469-6.50016-0 · Cited by 4
Žák, A., Tvrzická, E., Vecka, M., Romaniv, S., Zeman, M., & Konárková, M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04311.x · Cited by 3
Iloh, G. U. P. (2014) · American Journal of Health Research · doi:10.11648/j.ajhr.20140202.11 · Cited by 1
“[32] The associated risk factors include physical inactivity [6,15] and other enhancing risk factors.”
BackgroundObesity and Cardiovascular Risk Factors
Santi-Cano, M. J. (2013) · Obesity & Control Therapies Open Access · doi:10.15226/2374-8354/1/1/00105 · Cited by 4
“It is suggested that hypertriglyceridemic waist could have been helpful to identify non-obese metabolically unhealthy individuals with an excess of visceral adipose tissue [38].”
Avaliação por imagem da área de gordura visceral e suas correlações com alterações metabólicas
Roriz, A. K. C., Mello, A. L., Guimarães, J. F., dos Santos, F. C., Medeiros, J. M. B., & Sampaio, L. R. (2010) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2010005000159 · Cited by 3
Leiviskä, J., Sundvall, J., Jauhiainen, M., Kotseva, K., Tuomilehto, J., Backer, G. D., Tokgözoğlu, L. S., Reiner, Ž., & Bacquer, D. D. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120653 · Cited by 2
Regional and systemic adipose mass and peripheral conduit artery function
Wakeham, D. J., Beckman, B. E., Mashayekhi, M., Luther, J. M., Garner, E. M., Perkins, B., Gottlieb, J., Niswender, K. D., Hearon, C. M., Brown, N. J., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112408 · Cited by 2
Rauzier, C., Chartrand, D., Alméras, N., Lemieux, I., Larose, É., Mathieu, P., Pibarot, P., Lamarche, B., Rhéaume, C., Poirier, P., et al. (2024) · Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy · doi:10.2147/dmso.s466051 · Cited by 2
“22 This criterion corresponded to a value of 230 ng/mL in men (Supplementary Figure 2A) and 260 ng/mL in women (Supplementary Figure 2B), consistent with the observation that women had higher IGFBP-2 levels than men on average.”
MethodResultSelf-citationFinding a Link between Obesity and Senescence: A Systematic Review and Meta-Analysis
Widjaja, S. S., Rusdiana, R., Mardani, T. H., Simanullang, R. H., Jayalie, V. F., Amelia, R., & Arisa, J. (2024) · Iranian Journal of Public Health · doi:10.18502/ijph.v53i1.14679 · Cited by 1
Oliveira, J. G. D. S., Santos, B. D. C., Santos, R. K. F., Santos, C. B., Reis, A. R., Santos, C. F. D. S., de Carvalho, G. D., Brandão-Lima, P., Rocha, V. D. S., & Pires, L. V. (2023) · American Journal of Human Biology · doi:10.1002/ajhb.23999 · Cited by 2
“…a simple and low-cost tool to assist health professionals in the identification of individuals with the metabolic triad (hyperinsulinemia, elevated apolipoprotein B, and LDL-c) proposed by Lemieux et al. (2000) observed the increase in WC associated positively with the increase in apolipoprotein B.”
BackgroundHu, L., Liu, Y., Yang, K. Y., Chen, N., Ma, L., & Yan, Y. (2023) · HORMONES · doi:10.1007/s42000-023-00462-6 · Cited by 3
“They found that the hypertriglyceridemic-waist phenotype was a simple means of determining high risk for coronary artery disease (CAD) and the atherogenic metabolic triad [4] while also identifying this phenotype as a low-cost and easy screening tool.”
BackgroundLi, K., Cao, B., Ke, J., Yang, L.-Y., & Zhao, D. (2023) · Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy · doi:10.2147/dmso.s416668 · Cited by 2
“HWP is a particular biomarker that comprises both enlarged waist circumference and elevated TG. 8 First, Elevated triglyceride levels cause heparin to activate lipoprotein lipase and increase intravascular lipolysis of circulating triglycerides, thereby increasing tissue exposure to free fatty acids, ultimately leadin…”
BackgroundMethodInfluentialdos Santos, L., da Cruz, L. A., Fagunde, L. C., Mendes, J. M., Brito, T. A., Henrique-Fernandes, M., Coqueiro, R. D. S., & Carneiro, J. A. O. (2021) · Estudos interdisciplinares sobre o envelhecimento · doi:10.22456/2316-2171.98245 · Cited by 2
Insulin and glucose regulation at rest and during flight in a Neotropical nectar-feeding bat
Castro, D. L. J., de Freitas, R. M. P., Silva, S. B., de Melo, F. C. S. A., Sarandy, M. M., Ospina, E. G., Sartori, S. S. R., Gonçalves, R. V., & Freitas, M. B. (2021) · Mammalian Biology · doi:10.1007/s42991-021-00146-x · Cited by 3
Karásek, D., Spurná, J., Mačáková, D., Cibičková, Ľ., Krystyník, O., Kucerova, V., Úlehlová, J., & Slavík, L. (2021) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2021.0019 · Cited by 2
“2,7,13 Chronic inflammation and insulin resistance are likely to represent the link between visceral obesity and adverse metabolic changes.”
Metadata
- Authors
- Lemieux, I., Pascot, A., Couillard, C., Lamarche, B., Tchernof, A., Alméras, N., Bergeron, J., Gaudet, D., Tremblay, G., Prud’homme, D., Nadeau, A., & Després, J.-P.
- Affiliations
- Centre hospitalier de l'Université Laval (CA)
- From the Quebec Heart Institute, Laval Hospital Research Center; the Lipid Research Center, CHUL Research Center; the Physical Activity Sciences Laboratory, Laval University; the Diabetes Research Unit, CHUL Research Center, Ste-Foy; and the Lipid Clinic, Chicoutimi Hospital, Chicoutimi, Québec, Canada.
- ORCID
- Venue
- Circulation
- Published
- 2000-07-11
- Volume
- 102
- Issue
- 2
- Pages
- 179-184
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1991251155
- Cited by
- 937
- References
- 0
- Citations by year
- 2026: 10 · 2025: 19 · 2024: 23 · 2023: 28 · 2022: 31 · 2021: 29 · 2020: 30 · 2019: 26 · 2018: 35 · 2017: 29 · 2016: 38 · 2015: 38 · 2014: 42 · 2013: 42 · 2012: 49
- FWCI
- 18.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- Heart and Stroke Foundation of Canada
- Medical Research Council Canada
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- hypertriglyceridemic waist phenotype, waist circumference, fasting plasma triglycerides, hyperinsulinemia, apolipoprotein B, small dense LDL, coronary artery disease risk, cardiovascular screening, men
- MeSH terms
- Abdomen, Adult, Apolipoproteins B, Body Composition, Coronary Artery Disease, Coronary Disease, Humans, Hyperinsulinism, Lipoproteins, LDL, Male, Mass Screening, Middle Aged, Predictive Value of Tests, Risk Factors, Triglycerides, Hypertriglyceridemia, Biomarkers, Coronary Angiography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review